Table 3. Univariate and Multivariate Cox Proportional Hazard Ratio Modeling of Time to Progression.
| Univariate | Multivariate | |||
|---|---|---|---|---|
| Baseline Measure | HR* (95% CI) | p-value | HR* (95% CI) | p-value |
| CD4% (per 10% point decrease) | 2.0 (1.8-2.2) | 0.005 | 2.0 (1.8-2.1) | 0.013 |
| Log HIV RNA, copies/ml (per unit log increase) | 2.4 (1.9-3.0) | 0.002 | 1.8 (1.1-3.2) | 0.034 |
| % CD4 Cell Activation^ (per 10% increase) | 1.6 (1.5-1.6) | 0.05 | ||
| % CD8 Cell Activation ^ (per 10% increase) | 1.3 (1.3-1.3) | 0.05 | ||
| Hemoglobin < 9 g/dl | 3.1 (1.9-4.3) | 0.06 | ||
| HIV RNA > 100,000 (c/ml) | 2.0 (1.4-2.7) | 0.04 | ||
| CD4% < 25% | 1.6 (0.9-2.3) | 0.16 | ||
| Male~ | 2.0 (1.3-2.6) | 0.04 | ||
| Z-Score Weight-for-Age | 0.9 (0.6-1.1) | 0.21 | ||
| Age (per year increase) | 0.9 (0.7-1.0) | 0.09 | ||
| Age < 3 | 3.7 (1.7-8.0) | 0.001 | 3.0 (1.3-7.0) | 0.008 |
| CD4 count (cells/μl,, per 100 cell increase) | 1.0 (1.0-1.0) | 0.53 | ||
Hazard Ratio
% of cells expressing both CD38+HLADR+
did not remain significant when adjusted for HIV RNA.